Breaking News, Financial News

Roche

Group sales were up 9% in local currencies (lc).

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Roche 1Q10 1Q10 Revenues: $11.5 billion (+15%) Comments: Group sales were up 9% in local currencies (lc). Pharma sales were $9.1 billion, up 15% (6% lc), driven by the company’s oncology portfolio (+12% lc), with sales of Avastin up 18% to $1.8 billion. Diagnostics sales were up 16% (+7% lc) to $2.4 billion....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters